Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Miszta, Adam, Homa K. Ahmadzia, Naomi L. C. Luban, Shuhui Li, Dong Guo, Lori A. Holle, Jeffrey S. Berger, et al. “Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.” Journal of Thrombosis and Haemostasis : Jth, October 2020. https://doi.org/10.1111/jth.15114.
Oiron, Roseline d’, Sarah O’Brien, and Andra H. James. “Women and girls with haemophilia: Lessons learned.” Haemophilia, September 28, 2020. https://doi.org/10.1111/hae.14094.
Moreno-Duarte, Ingrid, Mary Cooter, Oluwatoyosi A. Onwuemene, Kamrouz Ghadimi, and Ian J. Welsby. “Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia.” Vox Sang, September 23, 2020. https://doi.org/10.1111/vox.13008.
Moreno-Duarte, Ingrid, Mary Cooter, Oluwatoyosi A. Onwuemene, Kamrouz Ghadimi, and Ian J. Welsby. “Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia.” Vox Sang, September 23, 2020. https://doi.org/10.1111/vox.13008.
Oh, Stephen T., Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srdan Verstovsek, Ruben Mesa, Carole B. Miller, et al. “ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial.” Blood Adv 4, no. 18 (September 22, 2020): 4282–91. https://doi.org/10.1182/bloodadvances.2020002662.
Thom, Howard, Jeroen Jansen, Jason Shafrin, Lauren Zhao, George Joseph, Hung-Yuan Cheng, Subhajit Gupta, and Nirmish Shah. “Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis.” Bmj Open 10, no. 9 (September 17, 2020): e034147. https://doi.org/10.1136/bmjopen-2019-034147.
Oyedeji, Charity I., Regina D. Crawford, and Nirmish Shah. “Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia.” J Natl Med Assoc, September 3, 2020. https://doi.org/10.1016/j.jnma.2020.08.007.
Ortel, Thomas L., Sreelatha Meleth, Diane Catellier, Mark Crowther, Doruk Erkan, Paul R. Fortin, David Garcia, et al. “Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis.” J Thromb Haemost 18, no. 9 (September 2020): 2274–86. https://doi.org/10.1111/jth.14936.
Stewart, Kearsley A., Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam-Tingang, Jill Powell, et al. “"Pain is Subjective": A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries.” Journal of Pain and Symptom Management, September 2020. https://doi.org/10.1016/j.jpainsymman.2020.08.029.
Li, Xihao, Zilin Li, Hufeng Zhou, Sheila M. Gaynor, Yaowu Liu, Han Chen, Ryan Sun, et al. “Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale.” Nat Genet 52, no. 9 (September 2020): 969–83. https://doi.org/10.1038/s41588-020-0676-4.